Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.

Molecular imaging and targeted radiotherapy with radiolabeled fibroblast activation protein inhibitor (FAPI) targeting peptide probes hold great potential for enhancing the clinical management of patients with FAP-expressing cancers. However, the high cost of PET probes has prompted us to search for new FAP-targeting single-photon imaging agents. In this study, HYNIC-Glc-FAPT is synthesized and radiolabeled with technetium-99m using tricine/EDDA or dimer tricine as coligands to produce [99mTc]Tc-tricine/EDDA-HYNIC-Glc-FAPT and [99mTc]Tc-tricine(2)-HYNIC-Glc-FAPT. Both [99mTc]Tc-tricine/EDDA-HYNIC-Glc-FAPT and [99mTc]Tc-tricine(2)-HYNIC-Glc-FAPT were effectively synthesized with an excellent radiochemistry yield (both >97%, n = 6) in a single-step technique, and their stability in PBS and human serum was satisfactory. Compared to [99mTc]Tc-tricine(2)-HYNIC-Glc-FAPT, [99mTc]Tc-tricine/EDDA-HYNIC-Glc-FAPT exhibited a more hydrophilic nature with a log P of -3.53 ± 0.12. In vitro cellular uptake and blocking assays, internalization, efflux experiments, and affinity experiments all suggested a mechanism with high FAP-specificity and affinity. SPECT imaging and biodistribution of [99mTc]Tc-tricine/EDDA-HYNIC-Glc-FAPT demonstrated sustained high tumor uptake in BALB/c nude mice bearing U87MG tumors for 6 h. It demonstrated a long-range retention characteristic and more rapid clearance ability from nontarget organs. Collectively, we successfully synthesized [99mTc]Tc-tricine/EDDA-HYNIC-Glc-FAPT and [99mTc]Tc-tricine(2)-HYNIC-Glc-FAPT, and the excellent targeting properties of [99mTc]Tc-tricine/EDDA-HYNIC-Glc-FAPT suggest a potential diagnostic value in future clinical studies for advanced-stage FAP-expressing malignancies, especially in prognostic evaluation of tumors for it low price and convenient source.

[1]  U. Reineke,et al.  Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  Ganghua Tang,et al.  Automatic Production and Preliminary PET Imaging of a New Imaging Agent [18F]AlF-FAPT , 2022, Frontiers in Oncology.

[3]  A. Rosato,et al.  Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging , 2022, Molecules.

[4]  K. Zhou,et al.  Chemical Synthesis of Antibody-Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy. , 2021, Journal of medicinal chemistry.

[5]  Xuran Zhang,et al.  Preparation and Bioevaluation of 99mTc-Labeled FAP Inhibitors as Tumor Radiotracers to Target the Fibroblast Activation Protein. , 2021, Molecular pharmaceutics.

[6]  A. Zelikin,et al.  Chemical (neo)glycosylation of biological drugs. , 2021, Advanced drug delivery reviews.

[7]  J. Debus,et al.  Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer , 2020, Molecular Imaging and Biology.

[8]  M. Mokhtary,et al.  Preparation and assessment of a new radiotracer technetium-99m-6-hydrazinonicotinic acid-tyrosine as a targeting agent in tumor detecting through single photon emission tomography. , 2020, Bioorganic chemistry.

[9]  P. Geramifar,et al.  Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen. , 2020, Bioorganic chemistry.

[10]  Thomas Lindner,et al.  Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy , 2020, The Journal of Nuclear Medicine.

[11]  Xuran Zhang,et al.  Preparation and evaluation of 99mTc-labeled HYNIC-palbociclib analogs for cyclin-dependent kinase 4/6-positive tumor imaging. , 2020, European journal of medicinal chemistry.

[12]  J. Giglio,et al.  99mTc Labelling Strategies for the Development of Potential Nitroimidazolic Hypoxia Imaging Agents , 2019, Inorganics.

[13]  Paul M. Levine,et al.  O-GlcNAc engineering of GPCR peptide-agonists improves their stability and in vivo activity. , 2019, Journal of the American Chemical Society.

[14]  Huawei Qiu,et al.  The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins. , 2019, Journal of pharmaceutical sciences.

[15]  D. Jäger,et al.  A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts , 2018, The Journal of Nuclear Medicine.

[16]  Thomas Lindner,et al.  Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein , 2018, The Journal of Nuclear Medicine.

[17]  Frederik L. Giesel,et al.  68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers , 2018, The Journal of Nuclear Medicine.

[18]  Wei Zhang,et al.  Effects of linker amino acids on the potency and selectivity of dimeric antimicrobial peptides , 2018, Chinese Chemical Letters.

[19]  J. G. Delinasios,et al.  Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts , 2018, Cancers.

[20]  S. Hosseinimehr,et al.  An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor. , 2018, European journal of medicinal chemistry.

[21]  Y. Kajihara,et al.  Chemical Synthesis of Glycoproteins with the Specific Installation of Gradient-Enriched 15 N-Labeled Amino Acids for Getting Insights into Glycoprotein Behavior. , 2017, Chemistry.

[22]  Zhiyuan Hu,et al.  SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models , 2017, The Journal of Nuclear Medicine.

[23]  A. Mathur,et al.  ‘4+1’ Mixed Ligand Strategy for the Preparation of 99mTc‐Radiopharmaceuticals for Hypoxia Detecting Applications , 2017 .

[24]  Xingzhong Zhao,et al.  Synthetic nanoparticles camouflaged with biomimetic erythrocyte membranes for reduced reticuloendothelial system uptake , 2016, Nanotechnology.

[25]  S. Rose-John,et al.  Semisynthesis of biologically active glycoforms of the human cytokine interleukin 6. , 2014, Angewandte Chemie.

[26]  Atul Kolate,et al.  PEG - a versatile conjugating ligand for drugs and drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[27]  C. Finucane,et al.  99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo , 2009, Journal of Nuclear Medicine.

[28]  R. J. Solá,et al.  Modulation of protein biophysical properties by chemical glycosylation: biochemical insights and biomedical implications , 2007, Cellular and Molecular Life Sciences.

[29]  C. Decristoforo,et al.  99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  H. Yanagie,et al.  Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[31]  R. Moncayo,et al.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives , 2000, European Journal of Nuclear Medicine.

[32]  K. Valentine,et al.  Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy. , 1999, Biochemistry.

[33]  Haladhar Dev Sarma,et al.  Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia. , 2016, Bioorganic & medicinal chemistry letters.

[34]  Xiangyun Wang,et al.  Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes. , 2012, Bioorganic & medicinal chemistry letters.